1. Home
  2. CIVI vs HRMY Comparison

CIVI vs HRMY Comparison

Compare CIVI & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CIVI
  • HRMY
  • Stock Information
  • Founded
  • CIVI 1999
  • HRMY 2017
  • Country
  • CIVI United States
  • HRMY United States
  • Employees
  • CIVI N/A
  • HRMY N/A
  • Industry
  • CIVI Oil & Gas Production
  • HRMY Biotechnology: Pharmaceutical Preparations
  • Sector
  • CIVI Energy
  • HRMY Health Care
  • Exchange
  • CIVI Nasdaq
  • HRMY Nasdaq
  • Market Cap
  • CIVI 2.5B
  • HRMY 2.0B
  • IPO Year
  • CIVI 2011
  • HRMY 2020
  • Fundamental
  • Price
  • CIVI $32.39
  • HRMY $31.89
  • Analyst Decision
  • CIVI Buy
  • HRMY Strong Buy
  • Analyst Count
  • CIVI 12
  • HRMY 9
  • Target Price
  • CIVI $49.60
  • HRMY $54.22
  • AVG Volume (30 Days)
  • CIVI 2.3M
  • HRMY 611.9K
  • Earning Date
  • CIVI 07-31-2025
  • HRMY 08-05-2025
  • Dividend Yield
  • CIVI 6.17%
  • HRMY N/A
  • EPS Growth
  • CIVI 5.61
  • HRMY 13.13
  • EPS
  • CIVI 8.73
  • HRMY 2.62
  • Revenue
  • CIVI $5,071,808,000.00
  • HRMY $744,852,000.00
  • Revenue This Year
  • CIVI N/A
  • HRMY $20.10
  • Revenue Next Year
  • CIVI N/A
  • HRMY $18.01
  • P/E Ratio
  • CIVI $3.71
  • HRMY $12.17
  • Revenue Growth
  • CIVI 22.15
  • HRMY 20.62
  • 52 Week Low
  • CIVI $22.79
  • HRMY $26.47
  • 52 Week High
  • CIVI $74.04
  • HRMY $41.61
  • Technical
  • Relative Strength Index (RSI)
  • CIVI 60.80
  • HRMY 36.85
  • Support Level
  • CIVI $31.94
  • HRMY $32.39
  • Resistance Level
  • CIVI $34.25
  • HRMY $33.42
  • Average True Range (ATR)
  • CIVI 1.48
  • HRMY 1.06
  • MACD
  • CIVI 0.43
  • HRMY -0.47
  • Stochastic Oscillator
  • CIVI 74.97
  • HRMY 6.91

About CIVI Civitas Resources Inc.

Civitas Resources Inc is an independent exploration and production company engaged in the acquisition, development, and production of oil and associated liquids-rich natural gas in the Rocky Mountain region, in the Denver-Julesburg Basin of Colorado - DJ Basin. The company's operations are focused on developing the horizontal Niobrara and Codell formations that have a low-cost structure, mature infrastructure, production efficiencies, multiple producing horizons, multiple service providers, established reserves, and prospective drilling opportunities.

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

Share on Social Networks: